Clinical Characteristics and Complications of Pediatric Liver Biopsy: A Single Centre Experience
Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 5
Abstract
Introduction. Percutaneous liver biopsy (LB) is the gold standard method for evaluation and management of patients with liver disease. The purpose of this study was to characterize pediatric patients undergoing LB at British Columbia Children's Hospital, and to determine the rate and timing of complications following the procedure. Material and methods. The medical records of all pediatric patients who underwent LB during a six-year retrospective study were reviewed to collect demographic and procedure-related data. Results. 223 LBs were performed, and 179 of these biopsies were percutaneous or transjugular. Elevated liver enzymes and cholestasis together accounted for almost 70% of the indications for LB, and the histological analysis of liver tissue yielded a specific diagnosis in 89 % of the cases. There were no deaths and no major complications related to LB. The most frequent minor complication was pain (59% of LBs) and the other complications were bleeding-related and classified as minor. The vast majority of complications (88%) were recognized within 8 h of the LB. Conclusions. LB is a valuable and safe procedure in pediatric patients with a low rate of complications. Pediatric patients can be discharged home safely should no complications occur within the first 8-12 h after the procedure.
Authors and Affiliations
Patricia Almeida, Richard A. Schreiber, Jennifer Liang, Quais Mujawar, Orlee R. Guttman
Keywords
Related Articles
- EP ID EP208910
- DOI 10.5604/01.3001.0010.2809
- Views 109
- Downloads 0
Pitfall alveolar echinococcosis in non-endemic areas Alveolar echinococcosis migrating northward
Alveolar echinococcosis of the liver can be mistaken as a liver tumor. The occurrence of the fox tapeworm echinococcus multilocularis is increasing in formerly unaffected European regions. As a consequence, alveolar echi...
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Background and aims. A subclassification system for intermediate hepatocellular carcinom...
The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats
[b]Background/aims[/b]. Hepatocellular carcinoma is one of the most commonly diagnosed malignant tumors in the world, and it typically has a poor prognosis. Extensive studies have examined the effects of non-steroidalant...
Cytokines as important playmakers of experimental hepatocarcinogenesis confounded by diabetes
Purpose. To explore the possible intermediary pathways through which diabetes mellitus (DM) adversely worsens hepatocellular carcinoma (HCC), focusing on cell life controllers as some transcription factors and inflammato...
Good outcomes of liver transplantation for hepatitis C at a low volume centre
Background and aims. Concerns exist about outcomes of liver transplantation (LT) from low volume centres, especially for hepatitis C (HCV) patients. The aim of the study was to assess patient outcomes as well as their pr...